%0 Journal Article
%T Factors impacting D-dimer levels in patients with acute ischemic cerebrovascular events.
%A Hacialioglu RA
%A Kielkopf M
%A Branca M
%A Clenin L
%A Boronylo A
%A Silimon N
%A Göldlin MB
%A Scutelnic A
%A Kaesmacher J
%A Mujanovic A
%A Meinel TR
%A Seiffge DJ
%A Heldner MR
%A Liberman AL
%A Navi BB
%A Fischer U
%A Arnold M
%A Jung S
%A Bücke P
%A Beyeler M
%J J Stroke Cerebrovasc Dis
%V 33
%N 8
%D 2024 Aug 26
%M 38936311
%F 2.677
%R 10.1016/j.jstrokecerebrovasdis.2024.107834
%X <B>OBJECTIVE: </B>A better understanding of the factors influencing D-dimer levels in code stroke patients is needed to guide further investigations of concomitant thrombotic conditions. This study aimed to investigate the impact of time from symptom onset and other factors on D-dimer levels in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).<BR><B>METHODS: </B>Data on consecutive AIS and TIA patients treated at our tertiary-care stroke center between January 2015 and December 2020 were retrospectively assessed. Patients with available D-dimer levels were evaluated for eligibility. Multivariable non-linear regression analyses were performed.<BR><B>RESULTS: </B>In total, 2467 AIS patients and 708 TIA patients were included. The median D-dimer levels differed between the AIS and TIA groups (746 µg/L [interquartile range 381-1468] versus 442 µg/L [interquartile range 244-800], p<0.001). In AIS patients, an early increase in D-dimer levels was demonstrated within the first 6 h (standardized beta coefficient [β] 0.728; 95% confidence interval [CI] 0.324-1.121). This was followed by an immediate decrease (β -13.022; 95% CI -20.401 to -5.643) and then by a second, late increase after 35 h (β 11.750; 95% CI 4.71-18.791). No time-dependent fluctuation in D-dimer levels was observed in TIA patients.<BR><B>CONCLUSIONS: </B>The time from symptom onset may affect D-dimer levels in patients with AIS but not those with TIA. Further studies confirming these findings and validating time-specific variations are needed to enable D-dimer levels to be used efficiently as an acute stroke and thrombotic risk biomarker.